文献速递糖尿病肥胖与代谢综合征

18-64岁拥有大型雇主保险的雇员中2型糖尿病相关的生产力损失与医疗费用

Productivity Loss and Medical Costs Associated With Type 2 Diabetes Among Employees Aged 18-64 Years With Large Employer-Sponsored Insurance.
PubMed 文献 · Diabetes Care · 2022-01-01

基于2018-2019年MarketScan数据库,分析18-64岁有缺勤、短期和长期残疾记录的雇员,估算2型糖尿病归因的生产力损失与医疗费用。2型糖尿病雇员人均年总费用高出近7000美元(11354 vs 5101美元),医疗费用翻倍,生产力成本高13.3%(680美元)。

要点

  • 2型糖尿病雇员较无糖尿病者多损失4.2天(缺勤20.8 vs 20.3天,短期残疾6.4 vs 3.3天,长期残疾1.0 vs 0.4天)。
  • 2型糖尿病雇员人均年医疗总费用为11354美元,无糖尿病者为5101美元。
  • 2型糖尿病雇员人均年生产力成本高13.3%(680美元)。

核心结论

  • 2型糖尿病使雇员人均年费用高出近7000美元,主要来自超额医疗费用。
  • 该估算可帮助雇主评估帮助员工预防或更好管理2型糖尿病的潜在财务收益。

研究设计与样本

  • 使用2018-2019年MarketScan数据库,在具有工作场所缺勤、短期残疾和长期残疾记录的雇员中识别2型糖尿病或无糖尿病者。
  • 估算2型糖尿病归因的人均年时间损失及相关费用(时间损失乘以平均小时工资),并估算直接医疗总费用及按服务类型划分的费用。
  • 采用两部分模型(生产力损失与费用、住院与药物费用)和广义线性模型(总费用与门诊费用)进行总体及按年龄和性别分层的分析,所有费用以2019年美元计。

主要发现

  • 2型糖尿病雇员较无糖尿病者多损失4.2天(缺勤20.8 vs 20.3天,短期残疾6.4 vs 3.3天,长期残疾1.0 vs 0.4天)。
  • 2型糖尿病雇员生产力成本高13.3%(680美元)。
  • 2型糖尿病雇员医疗总费用为无糖尿病者的两倍(11354 vs 5101美元);门诊费用4558 vs 2687美元,住院费用3085 vs 1349美元,处方药费用4182 vs 1189美元。
  • 18-34岁雇员短期残疾天数和门诊费用更高;女性较男性有更多缺勤和短期残疾天数及更高门诊费用。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate productivity losses and costs and medical costs due to type 2 diabetes (T2D) among employees aged 18-64 years. RESEARCH DESIGN AND METHODS: Using 2018-2019 MarketScan databases, we identified employees with T2D or no diabetes among those with records on workplace absences, short-term disability (STD), and long-term disability (LTD). We estimated per capita mean annual time loss attributable to T2D and its associated costs, calculated by multiplying time loss by average hourly wage. We estimated direct medical costs of T2D in total and by service type (inpatient, outpatient, and prescription drugs). We used two-part models (productivity losses and costs and inpatient and drug costs) and generalized linear models (total and outpatient costs) for overall and subgroup analyses by age and sex. All costs were in 2019 U.S. dollars. RESULTS: Employees with T2D had 4.2 excess days lost (20.8 vs. 20.3 absences, 6.4 vs. 3.3 STD days, and 1.0 vs. 0.4 LTD days) than those without diabetes. Productivity costs were 13.3% ($680) higher and medical costs were double (total $11,354 vs. $5,101; outpatient $4,558 vs. $2,687, inpatient $3,085 vs. $1,349, prescription drugs $4,182 vs. $1,189) for employees with T2D. Employees aged 18-34 years had higher STD days and outpatient costs. Women had more absences and STD days and higher outpatient costs than men. CONCLUSIONS: T2D contributes nearly $7,000 higher annual per capita costs, mostly due to excess medical costs. Our estimates may assist employers to assess potential financial gains from efforts to help workers prevent or better manage T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Park J, Bigman E, Zhang P, et al. Productivity Loss and Medical Costs Associated With Type 2 Diabetes Among Employees Aged 18-64 Years With Large Employer-Sponsored Insurance. Diabetes Care. 2022. PMID: 36048852. doi:10.2337/dc22-0445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。